PGXL, NX PharmaGen Team on Exosome Research Center | GenomeWeb

NEW YORK (GenomeWeb) – PGXL Technologies today said that it has formed a partnership with NX PharmaGen under which the partners have created a research center focused on exosome analysis.

The PGXL NeXosome Center of Excellence will utilize NX PharmaGen's NeXosome microparticle enrichment technology to support identification of biomarkers. The partners said they will provide access to the platform and assay development services in a CLIA setting to researchers and biopharmaceutical firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.